Weill Cornell

In Genome Biology this week: computational tool to uncover cancer driver mutations, microbial species linked to ankylosing spondylitis, and more.

The company hopes to raise funding this summer and has been conducting pilots with NewYork-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.

"Precision metagenomics" and "geospatially informed medical care" are among the long-term goals of the $5 million WorldQuant Initiative for Quantitative Prediction at Weill Cornell Medicine.

The medical school is launching the program with the support of a $5 million gift from investment firm WorldQuant and its founder.

Groups from Austria, Spain, Germany, and the US demonstrated that the GeneReader can reliably detect cancer mutations in tissue and liquid biopsy samples.

With new research and commercial test launches, clincians anticipate exciting new tools but judging quality and utility has become challenging.

Researchers hope to identify exosomal biomarkers that can predict or detect cancer recurrence and metastasis at its earliest stages.

This Week in Cell

In Cell this week: essential genes in AML, indel hotspots affect certain genes in cancer, and more.

Preliminary results from the NASA Twins Study indicate changes in DNA methylation and gene expression due to life in space, Nature News says.

The partners have committed to analyzing coding mutations, driver non-coding mutations, and structural variations across tumor types for the project.

Pages

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.